Latest news

Search
Categories
News archive

Nanologica Raises MSEK 79,8 in Rights Issue

10 October, 2022

 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.  Nanologica AB (publ) (”Nanologica” or the “Company”) today announces the outcome of the new shares issue with preferential rights for Nanologica’s existing shareholders (the

Read more »

Nanologica Receives Order for Silica for Preparative Chromatography from US Customer

3 October, 2022

Nanologica AB (publ) has received an order for the company’s silica for preparative chromatography to a value of approximately TSEK 230. The order comes from a customer in the North American market. During 2022, Nanologica has completed the up-scaling to large-scale production of the company’s commercial silica for preparative chromatography, NLAB Saga®.  This order is a direct consequence of the company now being able to deliver the volumes of silica required for customers to be

Read more »

CEO Comment in Connection with the Preferential Rights Issue 2022

20 September, 2022

In 2022, Nanologica has taken important steps forward in the chromatography business area. We have scaled up the production of our commercial silica for preparative chromatography, NLAB Saga®, to tonal scale, and we have sold the first products in preparative chromatography, as well as taken orders for NLAB Saga® for production-scale evaluation from one of the world’s largest insulin manufacturers. The fact that we now have products from our large-scale production means that we can

Read more »

Nanologica Publishes Prospectus in Connection with Preferential Rights Issue

20 September, 2022

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. The Board of Directors of Nanologica AB (publ) (“Nanologica” or the Company”) announced on 23 August 2022 that the Board of Directors has resolved

Read more »

Nanologica offentliggör prospekt med anledning av företrädesemission

20 September, 2022

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIEN, JAPAN, KANADA, HONG KONG, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA YTTERLIGARE REGISTRERINGS- ELLER ANDRA ÅTGÄRDER. Styrelsen för Nanologica AB (publ) (”Nanologica” eller Bolaget”) offentliggjorde den 23 augusti 2022 att styrelsen beslutat att genomföra en företrädesemission av aktier motsvarande cirka 94 MSEK (”Företrädesemissionen”). Styrelsens

Read more »